Showing results (211-220 of 218) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Kidney International|November 1, 2023
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)Wesley N Hayes, Emma Laing, Rosemary Brown, et al.Contemporary Clinical Trials|February 22, 2025
Intervention to reduce barriers to type 1 diabetes self-management: Diabetes Journey study design and participant characteristicsKimberly A Driscoll, Paige J Trojanowski, Desireé N Williford, et al.The New England Journal of Medicine|March 17, 2026
Prehospital Whole Blood in Traumatic Hemorrhage - a Randomized Controlled TrialJason E Smith, Rebecca Cardigan, Emily Sanderson, et al.Nature Genetics|June 23, 2014
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesisJamie M J Weaver, Caryn S Ross-Innes, Nicholas Shannon, et al.Open Biology|November 9, 2018
Phosphorylation of Parkin at serine 65 is essential for its activation in vivoThomas G McWilliams, Erica Barini, Risto Pohjolan-Pirhonen, et al.The Lancet Regional Health. Europe|July 30, 2025
Evaluation of a national digital pre-implantation biopsy service for deceased-donor kidney transplantation in the UK (Pithia trial); a stepped-wedge cluster randomised registry trialDominic M Summers, John O O Ayorinde, Desley A Neil, et al.Medrxiv : the Preprint Server for Health Sciences|March 11, 2026
Clinical, in vitro, and in vivo evidence of WAPL as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.American Journal of Human Genetics|July 10, 2026
Clinical, in vitro, and in vivo evidence of WAPL as a cohesinopathy-associated gene and phenotypic driver of 10q22.3q23.2 genomic disorderPhilip M Boone, Serkan Erdin, Abucar Mohamed, et al.Pageof 22